DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Boissy P, Andersen TL, Lund T. et al.
Pulse treatment with the proteasome inhibitor bortezomib inhibits osteoclast resorptive activity in clinically relevant conditions.
Leuk Res 2008; 32 (11): 1661-1668
Search in:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.